trending Market Intelligence /marketintelligence/en/news-insights/trending/9ep_wklibgofynexxrxrpa2 content esgSubNav
In This List

Inspyr Therapeutics' chief medical officer, directors resign

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Inspyr Therapeutics' chief medical officer, directors resign

Inspyr Therapeutics, Inc. said chief medical officer Ronald Shazer resigned from his position, effective Feb. 12.

Directors Peter Grebow and Richard Buller resigned from the company's board, effective Feb. 9.

The board resignations did not result from any disagreement with the company or matter relating to its operations, policies or practices, the Westlake Village, Calif.-based drug developer said in a Feb. 14 filing with the SEC.